Oxidized LDL, insulin resistance and central blood pressure after gestational diabetes mellitus

被引:6
作者
Vilmi-Kerala, Tiina [1 ,2 ]
Palomaki, Outi [3 ]
Kankkunen, Paivi [4 ,5 ]
Juurinen, Leena [6 ]
Uotila, Jukka [1 ,3 ]
Palomaki, Ari [1 ,7 ,8 ]
机构
[1] Univ Tampere, Sch Med, Tampere, Finland
[2] Kanta Hame Cent Hosp, Dept Obstet & Gynecol, Hameenlinna 13530, Finland
[3] Tampere Univ Hosp, Dept Obstet & Gynecol, Tampere, Finland
[4] VITA Healthcare Serv Ltd, Vita Lab, Helsinki, Finland
[5] Univ Helsinki, Fac Med, Dept Bacteriol & Immunol, Helsinki, Finland
[6] Kanta Hame Cent Hosp, Dept Internal Med, Hameenlinna, Finland
[7] Kanta Hame Cent Hosp, Dept Emergency Med, Hameenlinna, Finland
[8] Linnan Klin, Hameenlinna, Finland
关键词
Central blood pressure; gestational diabetes mellitus; homeostasis model assessment of insulin resistance; obesity; oxidized low-density lipoprotein; METABOLIC SYNDROME; ARTERIAL STIFFNESS; RISK-FACTORS; MARKER; WOMEN; MEN;
D O I
10.1111/aogs.13029
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction. Gestational diabetes mellitus (GDM) is an indicator of future cardiovascular disease. We investigated whether sensitive biomarkers of increased cardiovascular risk differ between women with and without a history of GDM few years after pregnancy, and whether obesity affects the results. Material and methods. We studied two cohorts -120 women with a history of GDM and 120 controls, on average 3.7 years after delivery. Circulating concentrations of oxidized low-density lipoprotein (oxLDL) were determined by ELISA. The homeostasis model assessment of insulin resistance (HOMA-IR) index was used to estimate insulin resistance. Central blood pressure (cBP) was measured noninvasively from a radial artery pulse wave. The primary outcomes were possible differences in oxLDL, HOMA-IR or cBP between the groups. Secondly, we investigated the influence of obesity on the results, also using adjusted multiple linear regression analyses. Results. OxLDL concentrations or cBP did not differ between the two cohorts, but HOMA-IR was significantly higher in women with previous GDM than in controls, 1.3 +/- 0.9 (SD) and 1.1 +/- 0.9, respectively (p = 0.022). In subgroup analyses, HOMA-IR (p < 0.001), systolic (p < 0.001) and diastolic (p < 0.001) cBP were significantly higher in obese subgroups compared with non-obese ones. Body mass index was an important determinant of HOMA-IR and cBP in multiple linear regression analyses. Conclusions. Over 3 years after delivery, women with GDM were still more insulin-resistant than controls. Obesity turned out to be a more important determinant of insulin resistance and cBP compared with GDM.
引用
收藏
页码:1425 / 1432
页数:8
相关论文
共 36 条
  • [1] Central blood pressure measurements and antihypertensive therapy a consensus document
    Agabiti-Rosei, Enrico
    Mancia, Giuseppe
    O'Rourke, Michael F.
    Roman, Mary J.
    Safar, Michel E.
    Smulyan, Harold
    Wang, Ji-Guang
    Wilkinson, Ian B.
    Williams, Bryan
    Vlachopoulos, Charalambos
    [J]. HYPERTENSION, 2007, 50 (01) : 154 - 160
  • [2] Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: A World Health Organization Guideline
    Agarwal, Mukesh M.
    Boulvain, Michel
    Coetzee, Edward
    Colagiuri, Stephen
    Falavigna, Maicon
    Hod, Moshe
    Meltzer, Sara
    Metzger, Boyd
    Omori, Yasue
    Rasa, Ingvars
    Schmidt, Maria Ines
    Seshiah, Veerasamy
    Simmons, David
    Sobngwi, Eugene
    Torloni, Maria Regina
    Yang, Huixia
    Balaji, V.
    Mendis, Shanthi P. B.
    Roglic, Gojka
    Merialdi, Mario
    Betran, Ana Pilar
    Jenum, Anne Karen
    Lao, Terence
    Lopez Stewart, Gloria
    Mikhailov, Anton
    Moses, Robert
    Samad, Noorjahan
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (03) : 341 - 363
  • [3] Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc11-S011, 10.2337/dc14-S081, 10.2337/dc13-S067, 10.2337/dc10-S011, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc12-s011, 10.2337/dc13-S011]
  • [4] [Anonymous], 2000, WHO TECH REP SER, V894, P1
  • [5] How can we measure insulin sensitivity/resistance?
    Antuna-Puente, B.
    Disse, E.
    Rabasa-Lhoret, R.
    Laville, M.
    Capeau, J.
    Bastard, J. -P.
    [J]. DIABETES & METABOLISM, 2011, 37 (03) : 179 - 188
  • [6] Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
    Bellamy, Leanne
    Casas, Juan-Pablo
    Hingorani, Aroon D.
    Williams, David
    [J]. LANCET, 2009, 373 (9677) : 1773 - 1779
  • [7] Glucose Intolerance after a Recent History of Gestational Diabetes
    Benhalima, Katrien
    Leuridan, Liesbeth
    Calewaert, Peggy
    Devlieger, Roland
    Verhaeghe, Johan
    Mathieu, Chantal
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
  • [8] Cohn JN, 1999, J HYPERTENS, V17, pS41
  • [9] Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort - Kaiser permanente of Colorado GDM screening program
    Dabelea, D
    Snell-Bergeon, JK
    Hartsfield, CL
    Bischoff, KJ
    Hamman, RF
    McDuffie, RS
    [J]. DIABETES CARE, 2005, 28 (03) : 579 - 584
  • [10] Fonseca VA, 2009, DIABETES CARE, V32, P1, DOI [10.2337/dc09-S301, 10.2337/dc09-9033]